THE NEW ORAL ANTIBIOTICS - WHAT THERAPEUTIC NICHE DO THESE AGENTS FILL

Seven new oral antimicrobial agents have entered the market in the pas t few years-azithromycin, clarithromycin, cefprozil, loracarbef, cefpo doxime, lomefloxacin, and enoxacin. Because of the number of competing products available, these new agents face closer scrutiny by drug dec ision makers with regard to their role within the therapeutic armament arium. This article discusses each of the seven new oral antimicrobial s and presents an analysis of their position in the marketplace and on a formulary.